SCHEMBL12712427

SCHEMBL12712427

CCC(CC)CN1C(=O)S/C(=C\c2ccc(O)c(C)c2)C1=O

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC2A1 P11166 2/20 0.73
▸ BAG3 O95817 1/20 0.56
▸ ALDH1A1 P00352 4/20 0.53
▸ MEN1 O00255 3/20 0.53
▸ MAPT P10636 3/20 0.53
▸ KMT2A Q03164 3/20 0.53
▸ LMNA P02545 2/20 0.53
▸ SMN1; SMN2 Q16637 2/20 0.53
▸ USP2 O75604 1/20 0.53
▸ POLB P06746 2/20 0.48
▸ PKM P14618 2/20 0.48
▸ BLM P54132 2/20 0.48
▸ TDP1 Q9NUW8 2/20 0.48
▸ KDM4E B2RXH2 1/20 0.48
▸ THRB P10828 1/20 0.48
▸ APEX1 P27695 1/20 0.48
▸ RECQL P46063 1/20 0.48
▸ NPSR1 Q6W5P4 1/20 0.48
▸ SAE1 Q9UBE0 1/20 0.48
▸ UBA2 Q9UBT2 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12712441 0.88 SLC2A1 (0.57) SLC2A1BAG3ALDH1A1MEN1MAPT
SCHEMBL12712428 0.87 SLC2A1 (0.57) SLC2A1BAG3ALDH1A1MEN1MAPT
SCHEMBL12712445 0.86 SLC2A1 (0.61) SLC2A1BAG3ALDH1A1MEN1MAPT
SCHEMBL1614379 0.84 SLC2A1 (1.00) SLC2A1BAG3ALDH1A1MEN1MAPT
SCHEMBL8172925 0.81 AKR1B1 (0.69) BAG3
SCHEMBL8172926 0.81 AKR1B1 (0.69) BAG3
SCHEMBL12712437 0.79 ENPP2 (0.64) ALDH1A1MEN1MAPTKMT2ASMN1; SMN2
SCHEMBL1613493 0.79 SLC2A1 (0.89) SLC2A1BAG3ALDH1A1MEN1MAPT
SCHEMBL12712430 0.78 PTPN1 (0.56) SLC2A1BAG3ALDH1A1MEN1MAPT
SCHEMBL1613879 0.77 SLC2A1 (0.57) SLC2A1BAG3ALDH1A1MEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8383656-B2 Thiazolidinedione energy restriction-mimetic agents THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2013-02-26 — — US disclosed
US-20110086895-A1 THIAZOLIDINEDIONE ENERGY RESTRICTION-MIMETIC AGENTS THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2011-04-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110086895-A1 THIAZOLIDINEDIONE ENERGY RESTRICTION-MIMETIC AGENTS PCK2, AK2, SIRT6 SLC2A1 76/4885BAG3 2468/4885ALDH1A1 839/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback